These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5051000)

  • 1. Dopamine -hydroxylase inhibitor produced by Gloeophyllum striatum and its identity with oosponol.
    Umezawa H; Iinuma H; Ito M; Matsuzaki M; Takeuchi T
    J Antibiot (Tokyo); 1972 Apr; 25(4):239-42. PubMed ID: 5051000
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of dopamine beta-hydroxylase by 5-alkylpicolinic acid and their hypotensive effects.
    Suda H; Takeuchi T; Nagatsu T; Matsuzaki M; Matsumoto I; Umezawa H
    Chem Pharm Bull (Tokyo); 1969 Nov; 17(11):2377-80. PubMed ID: 5363295
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of fusaric acid, inhibitor of dopamine -hydroxylase, on reaction to alcohol in chronic alcoholics: clinical findings.
    Ogata M; Sanada H; Teraoka M
    Folia Psychiatr Neurol Jpn; 1972 Jan; 26(1):1-5. PubMed ID: 5068469
    [No Abstract]   [Full Text] [Related]  

  • 4. Adrenal tyrosine hydroxylase and dopamine beta-hydroxylase in spontaneously hypertensive rats.
    Nagatsu I; Nagatsu T; Mizutani K; Umezawa H; Matsuzaki M; Takeuchi T
    Nature; 1971 Apr; 230(5293):381-2. PubMed ID: 4927727
    [No Abstract]   [Full Text] [Related]  

  • 5. BRL 8242 (2-[2-benzimidazolyl]-amino-2-imidazoline dihydrochloride), a new inhibitor of dopamine-beta-hydroxylase with antihypertensive activity.
    Claxton IM; Palfreyman MG; Poyser RH; Whiting RL
    Eur J Pharmacol; 1976 May; 37(1):179-88. PubMed ID: 1278239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusaric acid, a hypotensive agent produced by fungi.
    Hidaka H; Nagatsu T; Takeya K; Takeuchi T; Suda H
    J Antibiot (Tokyo); 1969 May; 22(5):228-30. PubMed ID: 5811396
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pyridinolcarbamate and bradykinin in the rat].
    Damas J; Lallemand G
    C R Seances Soc Biol Fil; 1974; 168(2-3):379-82. PubMed ID: 4282305
    [No Abstract]   [Full Text] [Related]  

  • 8. SCH 10595, an effective dopamine- -hydroxylase inhibitor and a hypotensive agent.
    Korduba CA; Veals J; Wohl A; Symchowicz S; Tabachnick II
    J Pharmacol Exp Ther; 1973 Mar; 184(3):671-7. PubMed ID: 4687230
    [No Abstract]   [Full Text] [Related]  

  • 9. Further characterization of the cardiovascular effects of the dopamine beta-hydroxylase inhibitor SK&F 102698 in conscious hypertensive rats.
    Ohlstein EH; Kruse LI; Ezekiel M; Willette RN
    J Pharmacol Exp Ther; 1988 Oct; 247(1):186-95. PubMed ID: 3050029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of bradykinin and histamine on capillary permeability].
    Gaponiuk PIa; Oĭvin VI
    Biull Eksp Biol Med; 1968 May; 65(5):31-4. PubMed ID: 5757798
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of the novel dopamine beta-hydroxylase inhibitor SK&F 102698 on catecholamines and blood pressure in spontaneously hypertensive rats.
    Berkowitz BA; Arleth AJ; Sung CP; Kruse LI; DeWolf WE; Ohlstein EH
    J Pharmacol Exp Ther; 1988 Jun; 245(3):850-7. PubMed ID: 3385645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Energetic aspects of the effect of histamine and bradykinin on vascular permeability].
    Gaponiuk PIa; Uklonskaia LI
    Biull Eksp Biol Med; 1974 Oct; 78(10):18-20. PubMed ID: 4156652
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of bradykinin on permeability of skin blood vessels.
    Oyvin IA; Gaponiuk PY; Oyvin VI
    Experientia; 1967 Nov; 23(11):925-6. PubMed ID: 6057009
    [No Abstract]   [Full Text] [Related]  

  • 14. Synergistic effect of histamine and bradykinin on capillary permeability.
    Mizuta K
    Mie Med J; 1970 Sep; 20(2):157-66. PubMed ID: 5514314
    [No Abstract]   [Full Text] [Related]  

  • 15. Dopastin, an inhibitor of dopamine -hydroxylase.
    Iimura H; Takeuchi T; Kondo S; Matsuzaki M; Umezawa H
    J Antibiot (Tokyo); 1972 Aug; 25(8):497-500. PubMed ID: 4648494
    [No Abstract]   [Full Text] [Related]  

  • 16. The mechanism of blood vessel permeability derangement under the influence of histamine, serotonin and bradykinin.
    Oyvin IA; Gaponyuk PY; Oyvin VI; Tokarev OY
    Experientia; 1970 Aug; 26(8):843-4. PubMed ID: 4393783
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological action of 6,7-dimethoxy coumarin (Scoparone) isolated from Artemisia scoparia, Waldst & Kit.
    Jamwal KS; Sharma ML; Chandhoke N; Ghatak BJ
    Indian J Med Res; 1972 May; 60(5):763-71. PubMed ID: 4663246
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacological properties and chemical structure of tetrahydro-gamma-carbolines].
    Shadurskiĭ KS; Il'iuchenok TIu
    Farmakol Toksikol; 1969; 32(4):482-5. PubMed ID: 4391083
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel antihypertensives targeted at dopamine beta-monooxygenase: turnover-dependent cofactor depletion by phenyl aminoethyl selenide.
    May SW; Wimalasena K; Herman HH; Fowler LC; Ciccarello MC; Pollock SH
    J Med Chem; 1988 Jun; 31(6):1066-8. PubMed ID: 3373481
    [No Abstract]   [Full Text] [Related]  

  • 20. Secondary fungal metabolites and their biological activities, III. Further metabolites from dual cultures of the antagonistic basidiomycetes Heterobasidion annosum and Gloeophyllum abietinum.
    Sonnenbichler J; Peipp H; Dietrich J
    Biol Chem Hoppe Seyler; 1993 Jul; 374(7):467-73. PubMed ID: 8216897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.